<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hereditary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> develops through a series of well-defined genetic and histological changes </plain></SENT>
<SENT sid="1" pm="."><plain>However, elucidation of the canonical pathway based on hereditary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has not provided a clear explanation of the molecular mechanisms of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To identify the alterative pathways involved in <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, we performed gene expression analysis in patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A comparison analysis of gene expression profiles revealed a pattern of upregulation of small proline rich repeat protein 3 (SPRR3) in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples </plain></SENT>
<SENT sid="4" pm="."><plain>SPRR3 has previously been reported to be downregulated in <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>However, in the present study, we observed that SPRR3 was strongly upregulated in 31 of 35 samples of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> (88%) </plain></SENT>
<SENT sid="6" pm="."><plain>We also determined that overexpression of SPRR3 not only accelerates <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell proliferation but also is associated with lymphovascular invasion in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, AKT was activated and p53 levels were decreased in cells that overexpressed SPRR3 </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast to the pattern seen in <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, these results suggest that increased expression of SPRR3 is involved in colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>